148 related articles for article (PubMed ID: 6231601)
21. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
[TBL] [Abstract][Full Text] [Related]
22. Ceftazidime for outpatient parenteral antibiotic therapy (OPAT) of chronic suppurative otitis media due to Pseudomonas aeruginosa.
Esposito S; Noviello S; Ianniello F; D'Errico G
J Chemother; 2000 Feb; 12(1):88-93. PubMed ID: 10768520
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
24. The use of azlocillin to treat serious infections.
Neu HC; Francke EL; Ortiz-Neu C; Prince AS
J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023
[TBL] [Abstract][Full Text] [Related]
25. Pseudomonas mastoiditis.
Meyerhoff WL; Gates GA; Montalbo PJ
Laryngoscope; 1977 Apr; 87(4 Pt 1):483-92. PubMed ID: 402522
[TBL] [Abstract][Full Text] [Related]
26. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
Elies W
Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
[TBL] [Abstract][Full Text] [Related]
27. Comparative clinical evaluation of azlocillin and gentamicin.
Sabbaj J; Torres M; Loza L
J Antimicrob Chemother; 1983 May; 11 Suppl B():175-81. PubMed ID: 6619027
[TBL] [Abstract][Full Text] [Related]
28. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children.
Madana J; Yolmo D; Kalaiarasi R; Gopalakrishnan S; Sujatha S
Int J Pediatr Otorhinolaryngol; 2011 Sep; 75(9):1104-8. PubMed ID: 21715027
[TBL] [Abstract][Full Text] [Related]
29. The use of fluoroquinolones in chronic otitis suppurativa.
van de Heyning PH; Pattyn SR; Valcke HD; van Caekenberghe DL; Claes J
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S87-9. PubMed ID: 3325935
[TBL] [Abstract][Full Text] [Related]
30. Ceftazidime in the treatment of chronic suppurative otitis media in children.
Lautala P; Vare M; Vuorinen O; Kaar ML
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():365-7. PubMed ID: 6352646
[TBL] [Abstract][Full Text] [Related]
31. Oral ciprofloxacin in the management of chronic suppurative otitis media without cholesteatoma in children: preliminary experience in 21 children.
Lang R; Goshen S; Raas-Rothschild A; Raz A; Ophir D; Wolach B; Berger I
Pediatr Infect Dis J; 1992 Nov; 11(11):925-9. PubMed ID: 1454433
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity and spectrum of bacterial isolates in infectious otitis externa.
Arshad M; Khan NU; Ali N; Afridi NM
J Coll Physicians Surg Pak; 2004 Mar; 14(3):146-9. PubMed ID: 15228846
[TBL] [Abstract][Full Text] [Related]
33. [Local treatment of otitis media and otitis externa: the role of quinolones].
De Schepper S; Schmelzer B
Acta Otorhinolaryngol Belg; 1994; 48(1):67-70. PubMed ID: 8172004
[TBL] [Abstract][Full Text] [Related]
34. [Clinical use of Kasugamycin for otological diseases due to Pseudomonas aeruginosa].
Ogura S; Kobayashi Y
J Antibiot B; 1967 Jun; 20(3):199-201. PubMed ID: 4965587
[No Abstract] [Full Text] [Related]
35. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa.
Vestin L; Burman LA; Holm S; Sellers J
Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781
[TBL] [Abstract][Full Text] [Related]
36. The development of antibiotic resistant organisms with the use of ototopical medications.
Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG
Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367
[TBL] [Abstract][Full Text] [Related]
37. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa.
Bernstein JM; Holland NJ; Porter GC; Maw AR
J Laryngol Otol; 2007 Feb; 121(2):118-23. PubMed ID: 16995959
[TBL] [Abstract][Full Text] [Related]
38. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
Canton P
Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
[TBL] [Abstract][Full Text] [Related]
39. The significance of Pseudomonas aeruginosa in chronic otitis media.
Stolp DL; Swart JG
S Afr Med J; 1989 Nov; 76(10):543-5. PubMed ID: 2511634
[TBL] [Abstract][Full Text] [Related]
40. Azlocillin--an antipseudomonas penicillin. Symposium: Dorado, Puerto Rico, 10-11 December 1982.
J Antimicrob Chemother; 1983 May; 11 Suppl B():1-239. PubMed ID: 6413480
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
